Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

partially HLA-matched multiple TAA-specific allogeneic T lymphocytes

A preparation of partially human leukocyte antigen (HLA)-matched allogeneic T lymphocytes targeting multiple tumor-associated antigens (TAAs), with potential immunomodulating and antineoplastic activities. Upon administration, partially HLA-matched multiple TAA-specific allogeneic T lymphocytes target and kill tumor cells expressing these TAAs.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:allogeneic partially HLA-matched multiple tumor-associated antigen-specific T cells
allogeneic partially-HLA-matched multiple TAA T cells
allogeneic TAA T cells
allogeneic TAA-T
allogeneic tumor-associated antigen-specific T cells
partially human leukocyte antigen-matched multiple tumor-associated antigen-specific allogeneic T lymphocytes
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search